Cargando…

Diagnostic efficacy of (18)F-FDG PET/CT in patients with adrenal incidentaloma

BACKGROUND: The management of adrenal incidentaloma is still a challenge with respect to determining its functionality (hormone secretion) and malignancy. In this light, we performed (18)F-FDG PET/CT scan to assess the SUV(max) values in different adrenal masses including Cushing syndrome, pheochrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Akkuş, Gamze, Güney, Isa Burak, Ok, Fesih, Evran, Mehtap, Izol, Volkan, Erdoğan, Şeyda, Bayazıt, Yıldırım, Sert, Murat, Tetiker, Tamer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599076/
https://www.ncbi.nlm.nih.gov/pubmed/31137014
http://dx.doi.org/10.1530/EC-19-0204
Descripción
Sumario:BACKGROUND: The management of adrenal incidentaloma is still a challenge with respect to determining its functionality (hormone secretion) and malignancy. In this light, we performed (18)F-FDG PET/CT scan to assess the SUV(max) values in different adrenal masses including Cushing syndrome, pheochromocytoma, primary hyperaldosteronism and non-functional adrenal adenomas. METHODS: Total 109 (73 F, 36 M) patients with adrenal mass (incidentaloma), mean age of 53.3 ± 10.2 years (range, 24–70) were screened by (18)F-FDG PET/CT. Data of (18)F-FDG PET/CT imaging of the patients were assessed by the same specialist. Adrenal masses were identified according to the calculated standardized uptake values (SUVs). Clinical examination, 24-h urine cortisol, catecholamine metabolites, 1-mg dexamethasone suppression test, aldosterone/renin ratio and serum electrolytes were analyzed. RESULTS: Based on the clinical and hormonal evaluations, there were 100 patients with non-functional adrenal mass, four with cortisol-secreting, four with pheochromocytomas and one with aldosterone-secreting adenoma. Mean adrenal mass diameter of 109 patients was 2.1 ± 4.3 (range, 1–6.5 cm). The (18)F-FDG PET/CT imaging of the patients revealed that lower SUV(max) values were found in non-functional adrenal masses (SUV(max) 3.2) when compared to the functional adrenal masses including four with cortisol-secreting adenoma (SUV(max) 10.1); four with pheochromcytoma (SUV(max) 8.7) and one with aldosterone-secreting adenomas (SUV(max) 3.30). Cortisol-secreting (Cushing syndrome) adrenal masses showed the highest SUV(max) value (10.1), and a cut-off SUV(max) of 4.135 was found with an 84.6% sensitivity and 75.6% specificity cortisol-secreting adrenal adenoma. CONCLUSIONS: Consistent with the similar studies, non-functional adrenal adenomas typically do not show increased FDG uptake and a certain form of functional adenoma could present various FDG uptake in FDG PET/CT. Especially functional adrenal adenomas (cortisol secreting was the highest) showed increased FDG uptake in comparison to the non-functional adrenal masses. Therefore, setting a specific SUV(max) value in the differentiation of malignant adrenal lesion from the benign one is risky and further studies, including a high number of functional adrenal mass are needed.